I don't look at this thread very often. Mainly because I see it as a minimal 3 year proposition, I also feel things are moving in the right direction. So no real fears there. [Apart from the cash burn]
However, I think it's difficult not to acknowledge that the remuneration packages particularly for the CEO are pretty generous. I also wonder why such a large executive team at this stage of the companies development.
But a good read out at the end of the Glioblastoma trial later this year may just give the sp a leg up. Then there is the question of funding for a Phase 2 ?
So happy to hold and see what happens.
CHM Price at posting:
6.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)